Valeant soars on takeover reports

Shares of Valeant Pharmaceuticals rose more than 9 percent Friday on reports that the company rejected a joint takeover bid earlier this year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.